Developed for:

Access Patients in Their Communities

Hawthorne Health is a community-based site network designed to support enrollment, retention, and execution.

Access changes everything.

Hawthorne Health is a pharmacy-based site network designed to support CROs, like Syneos Health, seeking to expand patient access through community-based clinical research across vaccine, infectious disease, rheumatology, cardiology, endocrinology, gastroenterology, and dermatology studies.

Our model engages patients through trusted healthcare settings, including clinics, pharmacies, and affiliated community care locations across the United States. Centralized operational oversight and standardized workflows support protocol-compliant execution while helping reduce barriers to participation and retention.

Pharmacy-Based Site Network

Built to reach patients traditionally excluded from existing research models, Hawthorne Health brings clinical trials to the heart of communities through a nationwide network of pharmacy-based sites.

Familiar settings and convenient locations help to reduce barriers to participation while improving patient retention and study outcomes.

Proposed Network Overview

We have identified a set of community-based sites and investigators aligned to support your pipeline, selected based on:

  • Existing patient flow within relevant populations

  • Established care relationships in local communities

  • Geographic distribution to support enrollment coverage

  • Ability to support both site-based and lower-burden visit structures

Hawthorne Site Demographics

Community Trial Solutions

Connecting Syneos Health to community-based care environments patients already utilize every day.

Benefits to Partnering with Hawthorne Health:

  • Eliminate patient barriers

  • Drive greater enrollment

  • Increase retention

  • Improve study compliance

Vaccine & Infectious Disease

Our deepest area of delivery. Sites have supported a range of vaccine and infectious disease programs, including Phase 3 efficacy and immunogenicity studies. Community access supports rapid, high-volume enrollment of healthy and at-risk populations.

Endocrinology & Metabolic

Type 2 diabetes, obesity, and metabolic programs, including SGLT2, finerenone, combination therapies, and GLP-1-class studies across communities with high cardiometabolic prevalence.

Cardiometabolic

Cardiovascular and cardiometabolic trial experience, including outcomes and event-driven programs, with investigators experienced in long-term retention and clean data submission.

Dermatology

Hawthorne Health supports dermatology studies through community-based investigators with experience serving diverse patient populations across established outpatient care settings.

Neurology

Our neurology capabilities are designed to support patient recruitment and retention through trusted local care relationships and geographically distributed investigator coverage.

Respiratory

Hawthorne’s respiratory capabilities combine community-based access with operational flexibility designed to support studies involving asthma, allergy, pulmonary, and chronic respiratory populations.

Rheumatology

Rheumatology and inflammatory disease experience, including autoimmune and musculoskeletal programs across Phase 2 and Phase 3 trials.

Operational Model

One operational partner across sites and homes.

Hawthorne’s operating model is designed to simplify study execution across community sites and in-home settings through centralized governance and standardized processes.

Capabilities include:

  • One CTA across participating community sites

  • Centralized feasibility and startup oversight

  • Standardized workflows and reporting

  • One project management structure across visit locations

  • Nationwide in-home support capabilities

  • 2,000+ GCP-trained clinicians

  • Coverage across all 50 U.S. states

  • 60,000+ completed at-home study visits

Kim DiCamillo

Head of Sales

With more than a decade of experience across clinical research, patient recruitment, and strategic partnerships, Kim has supported sponsors, CROs, and research organizations in accelerating study enrollment and expanding patient access.

Prior to joining Hawthorne Health as Head of Sales, Kim held commercial leadership roles at Profound Research, Sangamo Therapeutics, and Accelerated Enrollment Solutions, a division of PPD. Her experience spans community-based research, alliance management, decentralized trial strategies, and patient recruitment programs across a broad range of therapeutic areas.